Quarterly ResultMay 6, 2026, 04:09 PM
KORU Medical Q1 Revenue $11.8M, up 22%; Net Loss ($0.8M)
AI Summary
KORU Medical Systems reported first-quarter 2026 net revenues of $11.8 million, a 22% increase year-over-year, with gross profit growing 20% to $7.2 million. The company's net loss improved by 31% to ($0.8) million, or ($0.02) per diluted share. KORU Medical also reiterated its full-year 2026 guidance, expecting net revenues between $47.5 million and $50.0 million, and positive adjusted EBITDA and cash flow.
Key Highlights
- Q1 2026 net revenues increased 22.1% to $11.8 million.
- Gross profit grew 19.6% to $7.2 million, with a gross margin of 61.5%.
- Net loss improved 31% to ($0.8) million, or ($0.02) per diluted share.
- Adjusted EBITDA was ($0.01) million, an improvement from ($0.2) million in prior year.
- Domestic core revenues rose 11.7% to $7.7 million.
- International core revenues increased 35.2% to $3.3 million.
- Pharma services and clinical trials revenues surged 166.0% to $0.7 million.
- Reiterated full-year 2026 net revenue guidance of $47.5M-$50.0M.